cancer clinical trials in cincinnati, OH
Oncology & Hematology Care
Cincinnati, Ohio 45236 Multiple Myeloma
|
University of Cincinnati
Cincinnati, Ohio 45267-0502 Breast Cancer
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Gestational Trophoblastic Tumor
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Prostate Cancer
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Lung Cancer, Radiation Toxicity
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Lung Cancer
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Brain and Central Nervous System Tumors
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Leukemia
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Extraocular Retinoblastoma
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Leukemia
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia
|
University of Cincinnati
Cincinnati, Ohio 45267-0502 Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Neuroblastoma
|
University of Cincinnati
Cincinnati, Ohio 45267-0502 Neuroendocrine Carcinoma
|
UIMA, Inc / University of Cincinnati-Barrett Cancer Center
Cincinnati, Ohio 45267 NSCLC
|
University of Cincinnati
Cincinnati, Ohio 45267-0502 Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
Cincinnati Children's
Cincinnati, Ohio 45229 Tuberous Sclerosis Complex
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Colorectal Cancer
|
University of Cincinnati
Trial Locations University of Cincinnati Veterans Administration Medical Center - Cincinnati Stage IV Pancreatic Cancer
|
North Treatment Center - Blue Ash Medical Center
Trial Locations North Treatment Center - Blue Ash Medical Center Oncology/Hematology Care Clinical Trials LLC, Cincinnati, OH Blue Ash Med. Cntr. (Administrative Only) Oncology/Hematology Care Clinical Trials LLC Breast Cancer
|
The Jewish Hospital
Cincinnati, Ohio 45236 Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Neurofibromatosis Type 1
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Neuroblastoma
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Leukemia
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Childhood Atypical Teratoid/Rhabdoid Tumor
|
University of Cincinnati
Cincinnati, Ohio 45267-0502 Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Leukemia
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
|
Oncology Hematology Care
Cincinnati, Ohio 45242 Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Cincinnati, Ohio 45267 Non Small Cell Lung Cancer
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Retinoblastoma
|
Local Institution
Cincinnati, Ohio Metastatic Breast Cancer
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
|
University of Cincinnati / Barrett Cancer Center Dept.of Internal Med.
Cincinnati, Ohio 45219 Myelogenous Leukemia, Chronic
|
Good Samaritan Hospital Cancer Treatment Center
Cincinnati, Ohio 45220 Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
|
Bethesda North Hospital
Cincinnati, Ohio 45242 Breast Cancer
|
University of Cincinnati
Cincinnati, Ohio 45267-0502 Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
University of Cincinnati
Cincinnati, Ohio 45267-0502 Cancer, Multiple Indications
|
Christ Hospital
Cincinnati, Ohio 45219 Metastatic Castration-resistant Prostrate Cancer (mCRPC), Renal Cell Carcinoma (RCC), Metastatic Melanoma (MEL), Non-small Cell Lung Cancer (NSCLC)
|
Oncology Hematology Care
Cincinnati, Ohio 45242 Renal Cell Carcinoma
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
Oncology Hematology Care
Cincinnati, Ohio 45242 Carcinoma
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Lung Cancer
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Osteosarcoma
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Cincinnati, Ohio 45267 Non-small Cell Lung Cancer
|
Barrett Cancer Center
Cincinnati, Ohio 45267-0502 Melanoma
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|
University of Cincinnati
Cincinnati, Ohio 45267-0502 Recurrent Prostate Cancer
|
Oncology Hematology Care
Trial Locations Oncology Hematology Care The Christ Hospital B-cell Chronic Lymphocytic Leukemia
|
Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp
Cincinnati, Ohio 45229-3039 Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma
|
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio 45267-0526 Extrahepatic Bile Duct Cancer, Gallbladder Cancer
|
Oncology Partners Network
Cincinnati, Ohio 45238 Diffuse Large B-cell Lymphoma
|
Cincinnati Children's Hospital and Medical Center
Cincinnati, Ohio 45229 Juvenile Idiopathic Arthritis
|
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3039 Tuberous Sclerosis, Angiolipoma
|
The Jewish Hospital
Cincinnati, Ohio 45236 Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
|
Good Samaritan Hospital - Cincinnati
Trial Locations Good Samaritan Hospital - Cincinnati University of Cincinnati Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
Good Samaritan Hospital Cancer Treatment Center
Trial Locations Good Samaritan Hospital Cancer Treatment Center Oncology Hematology Care, Incorporated - Blue Ash Endometrial Cancer, Fatigue, Neurotoxicity
|